Clinical Trials Browser

Phase 3 × lifileucel × Dermatologic × Clear all

NCT06743126 2026-05-29

SUPRAME

Phase 3 Recruiting

Melanoma, Cutaneous Malignant

NCT05727904 2026-04-03

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Phase 3 Recruiting

Melanoma, Skin Neoplasms